Managing the Overlap: Therapeutic Approaches in Patients with Concomitant Psoriasis and Atopic Dermatitis—A Case Series

银屑病 医学 特应性皮炎 皮肤病科 白细胞介素23 贾纳斯激酶 免疫学 不利影响 炎症 白细胞介素17 药理学 细胞因子
作者
Maria Beatrice De Felici Del Giudice,Giorgia Ravaglia,Marco Brusasco,Francesca Satolli
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:14 (3): 796-796 被引量:8
标识
DOI:10.3390/jcm14030796
摘要

Introduction: Psoriasis (PSO) and atopic dermatitis (AD) have traditionally been considered distinct diseases, respectively, mediated by T-helper 1 (Th1) and the T-helper 2 (Th2) immune pathway. In recent years, there has been a growing body of evidence highlighting an overlap between the two conditions, such as Asian AD, pediatric PSO, or “psoriasis dermatitis/PSOREMA”. Moreover, psoriasis dermatitis can be induced by therapeutic interventions. For instance, anti-IL-4/IL-13 monoclonal antibodies, commonly used to treat AD, can induce psoriasiform reactions by inhibiting the Th2 pathway, thereby unmasking Th1/Th17-driven PSO. Conversely, anti-TNFα and anti-IL-17 therapies, effective for PSO, may induce eczematous reactions promoting a switch toward Th2-driven inflammation. Janus Kinase Inhibitors (JAK-i) and IL-23 antagonists may represent valid therapeutic options for managing psoriasis dermatitis. JAK-i exert broader immunomodulatory effects, inhibiting both Th1 and Th2 pathways; however, they require careful monitoring due to potential adverse events. In contrast, IL-23 antagonists specifically suppress the IL-23/IL-17 axis inhibiting the p19 subunit of IL-23 and could represent a safer option for patients with psoriasis dermatitis. Materials and Methods/Results: We present a series of five cases of psoriasis dermatitis, including both patients who had the condition from the onset and those who developed it during treatment, with tailored therapeutic strategies based on individual patient profiles, comorbidities, and the specific characteristics of their overlapping disease presentation. Conclusion: JAK-i and IL-23 antagonists are both valid therapeutic options for managing psoriasis dermatitis, but with different immunomodulatory effects and safety profiles. Future research should focus on a better understanding of the immune pathway and identifying specific biomarkers of psoriasis dermatitis, to optimize therapeutic strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
12发布了新的文献求助10
刚刚
刚刚
皮皮蛙完成签到,获得积分10
刚刚
乐乐的应助被聪明的梦梦采纳,获得10
刚刚
1秒前
2秒前
Jasper的应助被霁月采纳,获得10
3秒前
ZZ发布了新的文献求助10
4秒前
神秘人X发布了新的文献求助10
4秒前
nepdiana的应助被年轻的语儿采纳,获得30
4秒前
迷路凌柏发布了新的文献求助20
4秒前
5秒前
yzm发布了新的文献求助10
5秒前
聪明新梅完成签到,获得积分10
5秒前
李新宁发布了新的文献求助10
5秒前
5秒前
嘻嘻哈哈发布了新的文献求助210
5秒前
6秒前
pp009900发布了新的文献求助10
6秒前
西米露完成签到 ,获得积分10
6秒前
嘟嘟嘟嘟发布了新的文献求助10
7秒前
7秒前
8秒前
FashionBoy的应助被西瓜皮采纳,获得10
9秒前
李飘飘完成签到,获得积分10
9秒前
优秀曲奇完成签到,获得积分10
9秒前
zbn完成签到,获得积分10
9秒前
GSR完成签到,获得积分10
10秒前
叶渊舟完成签到,获得积分10
10秒前
MoonShy完成签到,获得积分10
10秒前
11秒前
11秒前
李新宁完成签到,获得积分10
11秒前
11秒前
完美世界的应助被SHNU_YS采纳,获得10
12秒前
李飘飘发布了新的文献求助10
12秒前
12秒前
无花果的应助被神奇高乐高采纳,获得10
13秒前
张立佳完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178375
求助须知:如何正确求助?哪些是违规求助? 9569182
关于积分的说明 21802781
捐赠科研通 7773247
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556793
邀请新用户注册赠送积分活动 2478346